When patients lose 1015% of their body weight, triglycerides often drop by 2030%, and LDL cholesterol may decrease by similar percentages
Thats what makes them relevant to psychiatric practice
Both are incretin-based peptides, but tirzepatide activates two receptors (GLP-1 + GIP) while semaglutide targets only GLP-1
The general dosing approach is: Starting dose: 8 mg once daily, taken at the same time each day if possible First step up: After at least 30 days, the dose may be increased to the next level (commonly 2.5 mg) Continued titration: Further increases happen at intervals of at least 30 days, moving up through 5.5 mg, 9 mg, and 12 mg as tolerated Maintenance dose: The maintenance dose is decided by your specialist based on how you tolerate the medication and the response you are seeing The tablet should be swallowed whole, not crushed, broken, or chewed
As obesity treatment increasingly shifts toward chronic care models supported by digital health infrastructure, the GLP-1 obesity home delivery injectables market is expected to maintain strong growth over the forecast period